11 Composite wafers and films comprising HPMC and sodium alginate (SA) were 12 formulated for nicotine (NIC) replacement therapy via the buccal route. 
Introduction 29
Nicotine has been utilised as an active ingredient in the development of NIC 30 replacement therapy (NRT) via the oral mucosa (chewing gum, sublingual tablets, 31 lozenges), nasal mucosa (nasal spray and inhalers) and the skin (transdermal patch). 32 NIC liquid is volatile, alkaline and colourless with two well-separated pKa values of 33 3.04 and 7.84, which can form diprotonated, mono-protonated and neutral NIC species 34 in an acid, neutral or basic solvent respectively (Pongjanyakul & Suksri, 2009 ). These 35 species can permeate membranes such as nasal, buccal and sublingual mucosae with 36 Alternative buccal delivery systems, which can be utilised in NRT using 48 mucoadhesive polymers have been under investigation including films (Aguzzi, Cerezo, 49 Viseras, & Caramella, 2007) and wafers (Aguzzi et HPMC is a hydrophilic non-ionic semi-synthetic polymer widely used in the 57 pharmaceutical and food industries while SA is a poly-anionic polysaccharide polymer 58 made up of alginic acid (a polyuronic acid composed of mannuronic and guluronic acid 59 residues), extracted from brown seaweed. HPMC-SA composites were reported for the 60 low rpm (100-200rpm) for 30 mins. 30 g of the NIC loaded MAS solutions were poured 109 into a Petri dish (90mm diameter) and dried in an oven at 30°C for 18-20 hrs. 110 Table 1 
Preparation of composite wafers 116
NIC loaded HPMC-SA-MAS solutions were prepared in a similar manner to films but 117 without using GLY. The solutions (1g) were poured into each well of a 24 well plate 118 Table 1b . The freeze-dried wafers were prepared using an 120 automated lyophilisation cycle, Virtis Advantage XL 70 freeze-dryer (Biopharma 121 process systems, Winchester, UK). The well plates containing the gels were loaded onto 122 the shelves of the freeze-dryer and programmed for freezing, primary drying and 123 secondary drying steps. The freezing step involved cooling the sample from room 124 temperature to 5°C (40 mins), 5°C to -10°C (40 mins), and then from -10°C to -55°C 125 (120 mins). An annealing step was incorporated into the freezing cycle by increasing 126 the temperature from -55°C to -35°C (2 hrs) and then cooling back down to -55°C (3 127 hrs). Additional freezing was performed at -55°C (1 hr) with a condenser temperature of 128 -55°C under pressure (200mTorr). The primary drying occurred under high pressure of 129 50mTorr. The temperature was raised from -55°C to -20°C (8 hrs) and further increased 130 from -20°C to -15°C ° (10 hrs). Secondary drying occurred at 50mTorr, from -15°C to 131 25°C (12.5 hrs). 132
Polymer solution properties 133
The polymeric solutions were analysed for surface stickiness, stringiness and gel 134 strength using a texture analyser (HD plus, Stable Micro System, Surrey, UK) equipped 135 with a 5 kg load cell. A 25mm probe was lowered onto the solution at a speed of 136 1mm/sec, held for 2 sec, and then withdrawn at a speed of 8mm/sec. The maximum 137 force at withdrawal of probe from sample was recorded as surface stickiness while the 138 distance from the onset and offset of force while moving the probe away from the 139 sample was recorded as stringiness. The viscous 'gel' strength was recorded as the 140 maximum force as the probe penetrated the polymeric solution to the required depth. 141 2.5 Mechanical characterization using texture analysis (TA) 142
Tensile properties of films 143
The tensile properties of the films were analysed using a texture analyser (HD plus, 144
Stable Micro System, Surrey, UK) equipped with a 5 kg load cell. The films (dumb-bell 145 shaped) were fixed between two tensile grips of the TA instrument and then stretched at 146 a test speed of 2mm/sec till breaking point. The elongation at break (%), tensile strength 147 and elastic modulus were determined (n=3) (Morales & McConville, 2011) . 148
Mechanical properties of wafers (hardness) 149
The resistance to compressive deformation (hardness) of the freeze dried wafers was 150 determined using a texture analyser (HD plus, Stable Micro System, Surrey, UK) 151 equipped with a 5 kg load cell. The wafers were compressed to a depth of 2mm using a 152 2mm cylinder stainless steel probe in compression mode at a speed of 1mm/sec. Wafers 153 were compressed on 5 different sides (n=3). 154
Scanning electron microscopy (SEM) 155
The surface morphology of films and wafers were analysed using a Hitachi SU8030 156 (Hitachi High-Technologies, Krefeld, Germany) scanning electron microscope. 157
Formulations were cut and placed on an Agar Scientific G301 aluminium pin-type 158 stubs, using an Agar Scientific G3347N double-sided adhesive carbon tape. The films 159 were carbon coated, while wafers were gold coated using a Sputter Coater (Edwards 160 188 Sputter Coater S1508). The films and wafers were analysed at 2.0kV and 5.0kV 161 accelerating voltage respectively. 162
Wafer porosity 163
Pore analysis was performed in order to evaluate the porosity of wafer structure. The 164 wafers were initially weighed and then immersed in 5ml of ethanol in a glass vial and 165 left to stand for 10 mins to allow complete saturation with ethanol. The vials with 166 ethanol and wafers were degassed to remove air bubbles entrapped in the wafers for 10 167 mins. The wafers were carefully removed from the solvent, gently wiped to remove 168 excess solvent, and immediately weighed, to minimise loss of ethanol. 169
The percentage porosity of wafers was calculated using equation 1 below: 170 
X-ray diffraction (XRD) 178
The physical (crystalline/amorphous) form of NIC loaded MAS films and wafers was 179 investigated using a D8 Advantage X-ray diffractometer. Films were cut into small 180 pieces whilst wafers were compressed, placed on the holder and mounted onto the 181 sample cell. For pure starting materials, mylar was used to hold the powders before 182 placing on the sample cell. The samples were analysed in transmission mode at a 183 diffraction angle ranging from 5° to 50° 2θ, step size 0.04°, and scan speed of 0.4s/step. 
Mucoadhesion 205
Adhesion test was performed on films and wafers using a TA. HD plus texture analyser 206 (Stable micro systems, Surry, UK) in tensile mode and fitted with a 5kg load cell. Films 207 were cut to match the mathematical area of wafers (a circle with diameter = 15.5mm). 208
The formulations were attached to an adhesive probe (75mm diameter) of the TA 209 instrument using a double-sided adhesive tape. Gelatine solution (6.67% (w/v)) 210 prepared at 70°C (stirred at 500-700rpm) was poured into a Petri dish (86mm diameter) 211
and immediately placed in a fridge overnight (16-20 hrs) to set into solid gel, and 0.5 ml 212 of mucin solution (2% (w/v)) prepared in phosphate buffered saline (pH 6.8; ionic 213 strength, 0.07M) at room temperature was evenly spread on the gelatine gel to represent 214 the buccal mucosa. The probe with formulation attached was lowered to make contact 215 with the model buccal mucosa surface for 60 sec, at an applied force of 1.00N, and then 216 detached. Mucoadhesive strength was determined by the peak adhesive force (PAF) 217 required to detach the sample from the gelatine surface, total work of adhesion (TWA) 218 was determined by the area under the force-distance curve, while cohesiveness 219 represents the distance the samples travelled till they detached from the model buccal 220 surface. Texture Exponent 32 ® software was used in collecting and processing the data 221 from the TA analyser. 222
High performance liquid chromatography (HPLC) 223
NIC was analysed by HPLC using an Agilent 1200 HPLC instrument (Agilent 224
Technologies, Cheshire, UK) with an auto sampler. The column used was a C-18 225 reverse-phase column, 4.6 x 250mm (Phenomenex, Cheshire, UK). Trimethylamine, 226 methanol and sodium acetate (88:12:0.5 v/v) were used as mobile phase and pH 227 adjusted to 4.2 using glacial acetic acid. Mobile phase flow rate was 1ml/min and 228 wavelength detection was set at 259nm (Pongjanyakul & Suksri, 2010) . The retention 229 time of NIC was detected at approximately 4.5 min. Calibration curve was plotted using 230 standards with NIC concentration ranging from 40µg/ml to 400µg/ml (R 2 =0.9994). 231
Drug content 232
The content of NIC in NIC loaded MAS films and wafers was assayed by accurately 233 weighing and dissolving films and wafers in 10ml of distilled water. The films and 234 wafers were accurately weighed (20-40mg) and recorded in determining the drug 235 content. The resulting solution was collected into a syringe, filtered through a 0.45µm 236 cellulose acetate membrane, transferred into HPLC vials and placed in HPLC sample 237 chamber and analysed as described above (n=3). 238
In vitro drug dissolution 239
In vitro drug dissolution of NIC loaded films and wafers was performed using a Franz-240 diffusion cell apparatus. The receptor compartment was filled with 8ml of phosphate 241 buffer (pH 6.8) with a mesh (1mm mesh size) on the receptor surface. The donor and 242 receptor compartments were sealed with paraffin to limit evaporation and held together 243 
Statistical analysis 259
The results were expressed as mean (± standard deviation) and statistical analysis was 260 performed using student t-test and / or one-way ANOVA to compare results. The 261 significant differences of data were determined at a level of p < 0.05. 262
Results 263

Polymer solution properties 264
The pH of the HPMC-SA solutions was neutral but increased to between pH 9-10 upon 265 addition of NIC. NIC loaded HPMC-SA-MAS solutions were less viscous and 266 therefore flowed easily when poured into both the well plates and Petri-dishes for 267 wafers and films respectively. 268 The HPMC-SA-MAS solutions (Table 2) Generally, the result supports SEM results wafers with a better pore structure and 340 homogeneity observed for HPMC-SA wafer with no MAS present (i.e. MAS 0.00). 341
XRD analysis 342
Figure S2 
361
The characteristic peaks and band assignments of pure polymers, GLY, MAS, NIC, and 362 NIC loaded composite wafers and films are summarised in Tables A1 and A2  363 respectively (supplementary data). NIC loaded wafers and films demonstrated a shift to 364 higher wavenumber for O-H, O-C=O (asymmetric) and (symmetric) stretching bands. 365
The Si-O-Al (octahedral Al), characteristic peak of MAS at 517cm -1 was demonstrated 366 in MAS loaded wafers, with a shift to higher wavelength at 518cm -1 , but showed a shift 367 to lower wavenumber at 516cm -1 for the corresponding films. However, films without 368 MAS demonstrated a characteristic C-H peak of GLY with a shift to lower wavenumber 369 and C-CH3 characteristic peak of HPMC (1314cm -1 ) with a shift to higher wavenumber 370 
Drug release kinetics 444
The release parameters of NIC loaded SA based wafers and films have been 445 summarised in Tables A3 and A4 The mechanical hardness of wafers is related to their handling and friability and 462 therefore consistency of wafer structure can be demonstrated using hardness data as this 463
shows their resistance to compression deformation forces (Boateng & Areago, 2014) . decrease in mucoadhesion of wafers as MAS concentration increased could be due to 508 the poor contact stage caused by gaps related to the sponge-like pores present in wafers 509 (Smart, 2005) . In addition, MAS can compete with SA and NIC for binding mucin. 510
However, the increase in MAS showed no noticeable change in adhesion, as the freely 511 available MAS after interaction with NIC, interacts with SA, therefore reducing the 512 availability of the SA cationic group to interact with mucin. 513
The primary aim of incorporating MAS into HPMC-SA wafers and films was to 514 stabilise NIC. The volatility of NIC base is one of the main reasons for its instability in 515 formulations as NIC evaporates at high temperature during the drying process (Nair et 516 al., 1997) . MAS can readily interact with amine based drugs through electrostatic 517 interactions which can improve NIC stability (Pongjanyakul & Suksri, 2009 ). However, 518 higher percentage NIC content was observed in wafers than in the films due to the lower 519 temperatures used during freeze-drying, compared oven drying. The decrease in 520 percentage NIC content in MAS wafers and films at MAS 0.50 and 0.75 can be 521 explained by the increase in repulsive forces which build-up as MAS concentration 522 increased. 523
The release of drug from polymeric matrices such as wafers and films is 524 dependent on factors such as hydration and eventual swelling of the polymeric dosage 525 form (Siepmann & Peppas, 2012) . As formulations come in contact with dissolution 526 medium, they undergo hydration, swelling and erosion (dissolution), which was evident 527 in the swelling behaviour of the various wafers and films. The rapid release (80 -100% 528 in 60 mins) of the wafers corresponded to the high swelling index, due to the sponge-529 like porous internal structure of wafers (SEM and percentage porosity). Therefore, the 530 use of SA based wafers can be efficient in achieving rapid release of NIC to the buccal 531 mucosa to ensure rapid easing of the urge to smoke tobacco. The much slower release 532 of NIC from the films, which corresponded to low swelling index, can be important in 533 achieving sustained release of NIC, with an extended effect to reduce the need for 534 frequent administration. The release exponents of MAS loaded formulations of less than 535 0.45 was outside the limits of Korsmeyer-Peppas model and also highlights the 536 limitations of the Korsmeyer-Peppas model in the understanding of drug release 537 mechanisms (Shoaib, Tazeen, Merchant, & Yousuf, 2006) . However, the release 538 exponent of 0.48 for wafers without MAS (MAS 0.00 wafers) shows that drug release 539 from these wafers followed a Fickian diffusion transport mechanism (Nair et al., 2013) . 540
Conclusions 541
Composite SA based films and wafers, incorporating MAS have been successfully 542
